FDA Updates Dietary Supplement cGMP Paperwork Requirements

The FDA is streamlining how dietary supplement manufacturers report current Good Manufacturing Practice (cGMP) compliance. If you import or manufacture supplements, this paperwork change could affect your filing burden. Here is what you need to know.

What Are cGMP Requirements for Dietary Supplements?

Federal regulations govern the manufacture, packaging, labeling, and holding of dietary supplements sold in the United States. These rules require companies to maintain detailed records. They also require written procedures for every stage of production. Importers bringing supplements into the U.S. must meet the same standard as domestic manufacturers.

Failure to comply can trigger import alerts, product holds, or refusal of entry at the border.

What Is Changing With the Paperwork?

The FDA has been reviewing its information collection requirements under the Paperwork Reduction Act. The agency periodically updates the estimated burden hours it places on industry. Recent notices signal a refinement in how cGMP-related documentation is reported and tracked.

Specifically, the FDA is adjusting the estimated hours manufacturers and importers spend on:

• Batch production records and their associated review steps

• Supplier verification documentation under supply chain controls

• Written standard operating procedures (SOPs)

These adjustments affect how the agency calculates your overall compliance burden. They do not eliminate any existing requirements. Every record-keeping obligation under Part 111 remains in force.

Why This Matters for Importers

Importers often underestimate the documentation load tied to cGMP compliance. When your foreign supplier ships a dietary supplement to the U.S., you are responsible for confirming that product was manufactured under conditions equivalent to U.S. standards.

That means you need supplier audit records, certificates of analysis, and manufacturing documentation ready before your shipment arrives at the port of entry. The FDA can and does inspect these records.

If your paperwork is incomplete, the agency can place your products on import alert. That stops future shipments automatically, without additional review.

What Should You Do Right Now?

Start by auditing your current documentation practices against the actual text of 21 CFR Part 111. Ask yourself:

- Do you have signed batch records for every lot you import?

- Is your supplier qualification program documented and current?

- Are your SOPs written, dated, and accessible to reviewers?

If the answer to any of these is no, close that gap before your next shipment arrives.

Also, watch the FDA's official notices in the Federal Register. When the agency updates its information collection estimates, it publishes a comment period. That window is an opportunity to understand what documentation the FDA is focused on.

Plain-English Takeaways

• 21 CFR Part 111 still governs all cGMP requirements. Nothing has been removed.

• The FDA is refining its burden estimates. Your actual obligations stay the same.

• Importers carry responsibility for supplier compliance, not just their own operations.

• Incomplete records at entry can lead to import alerts and shipment refusals.

Work With a Compliance Partner

Staying current with FDA paperwork requirements takes time and expertise. US Imports helps dietary supplement importers build documentation systems that hold up under FDA scrutiny. Whether you are setting up supplier verification programs or reviewing your cGMP records, our team is ready to help.

Get started today: https://www.usimports.us/services